Laboratorios Richmond SACIF (RICH) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.003x

Based on the latest financial reports, Laboratorios Richmond SACIF (RICH) has a cash flow conversion efficiency ratio of 0.003x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AR$202.02 Million ≈ $146.18K USD) by net assets (AR$72.73 Billion ≈ $52.63 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Laboratorios Richmond SACIF (RICH) defensive interval to measure how many days the company can operate on defensive assets alone.

Laboratorios Richmond SACIF - Cash Flow Conversion Efficiency Trend (2006–2024)

This chart illustrates how Laboratorios Richmond SACIF's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Laboratorios Richmond SACIF Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Laboratorios Richmond SACIF ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Nurol Gayrimenkul Yatirim Ortakligi AS IS:NUGYO	0.016x
Deutsch Motors Inc KQ:067990	0.046x
LIG-ES SPAC KQ:220260	0.025x
Se Gyung Hi Tech Co.Ltd KQ:148150	0.004x
Superior Plating Technology Co Ltd TWO:8431	-0.024x
Nanexa AB ST:NANEXA	-0.040x
Datagate Bilgisayar Malzemeleri Ticaret AS IS:DGATE	2.440x
PolyPid NASDAQ:PYPD	-2.876x

Annual Cash Flow Conversion Efficiency for Laboratorios Richmond SACIF (2006–2024)

The table below shows the annual cash flow conversion efficiency of Laboratorios Richmond SACIF from 2006 to 2024. For the full company profile with market capitalisation and key ratios, see RICH stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	AR$65.35 Billion ≈ $47.29 Million	AR$5.62 Billion ≈ $4.07 Million	0.086x	+194.63%
2023-12-31	AR$49.98 Billion ≈ $36.17 Million	AR$-4.54 Billion ≈ $-3.29 Million	-0.091x	+78.32%
2022-12-31	AR$10.22 Billion ≈ $7.39 Million	AR$-4.29 Billion ≈ $-3.10 Million	-0.419x	-131.00%
2021-12-31	AR$5.38 Billion ≈ $3.89 Million	AR$7.27 Billion ≈ $5.26 Million	1.353x	+2622.42%
2020-12-31	AR$3.38 Billion ≈ $2.45 Million	AR$-181.33 Million ≈ $-131.21K	-0.054x	-193.08%
2019-12-31	AR$2.10 Billion ≈ $1.52 Million	AR$121.02 Million ≈ $87.57K	0.058x	+135.14%
2018-12-31	AR$1.11 Billion ≈ $803.87K	AR$-182.16 Million ≈ $-131.81K	-0.164x	-1109.58%
2017-12-31	AR$688.05 Million ≈ $497.88K	AR$11.18 Million ≈ $8.09K	0.016x	+183.82%
2016-12-31	AR$189.46 Million ≈ $137.09K	AR$-3.67 Million ≈ $-2.66K	-0.019x	+92.67%
2015-12-31	AR$96.12 Million ≈ $69.55K	AR$-25.42 Million ≈ $-18.40K	-0.264x	-477.45%
2011-12-31	AR$50.10 Million ≈ $36.26K	AR$3.51 Million ≈ $2.54K	0.070x	-62.15%
2010-12-31	AR$44.82 Million ≈ $32.43K	AR$8.30 Million ≈ $6.00K	0.185x	+694.54%
2009-12-31	AR$53.73 Million ≈ $38.88K	AR$1.25 Million ≈ $905.95	0.023x	-95.41%
2007-12-31	AR$13.25 Million ≈ $9.59K	AR$6.73 Million ≈ $4.87K	0.508x	-69.41%
2006-12-31	AR$7.75 Million ≈ $5.61K	AR$12.87 Million ≈ $9.31K	1.661x	--

About Laboratorios Richmond SACIF

BA:RICH Argentina Drug Manufacturers - Specialty & Generic

Market Cap

$77.81 Million

AR$107.53 Billion ARS

Market Cap Rank

#20254 Global

#56 in Argentina

Share Price

AR$1615.00

Change (1 day)

-0.31%

52-Week Range

AR$970.00 - AR$2165.00

All Time High

AR$2165.00